These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16117708)

  • 1. Therapeutic immunization strategies for the control of HIV-1.
    Dorrell L
    Expert Rev Vaccines; 2005 Aug; 4(4):513-20. PubMed ID: 16117708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of therapeutic vaccines in the control of HIV-1.
    Kinloch-de Loes S
    J Antimicrob Chemother; 2004 Apr; 53(4):562-6. PubMed ID: 14985273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune reconstitution in HIV-1-infected patients.
    Imami N; Hardy G; Pires A; Burton C; Pido-Lopez J; Mela C; Gotch F
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1138-45. PubMed ID: 12211404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunopathogenesis and therapeutic immunization in HIV-infection].
    Kran AM; Kvale D
    Tidsskr Nor Laegeforen; 2006 Nov; 126(23):3112-6. PubMed ID: 17160117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained control of viremia following therapeutic immunization in chronically HIV-1-infected individuals.
    Lévy Y; Durier C; Lascaux AS; Meiffrédy V; Gahéry-Ségard H; Goujard C; Rouzioux C; Resch M; Guillet JG; Kazatchkine M; Delfraissy JF; Aboulker JP;
    AIDS; 2006 Feb; 20(3):405-13. PubMed ID: 16439874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy and therapeutic vaccines in HIV infection.
    García F; Ruiz L; López-Bernaldo de Quirós JC; Moreno S; Domingo P
    Enferm Infecc Microbiol Clin; 2005 Jul; 23 Suppl 2():84-104. PubMed ID: 16373008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic immunization for the control of HIV-1: where are we now?
    Dorrell L
    Int J STD AIDS; 2006 Jul; 17(7):436-41; quiz 442. PubMed ID: 16820070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Various approaches of therapeutic vaccination for the treatment of HIV type 1 infection].
    Lazrek M; Lobert PE; Goffard A; Schanen C; Dewilde A; Bocket L; Hober D
    Ann Biol Clin (Paris); 2005; 63(6):581-8. PubMed ID: 16330376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New strategies to combat HIV: augmenting antiviral immunity.
    Smith KA; Boyle BA
    AIDS Read; 2003 Aug; 13(8):365-9, 382. PubMed ID: 14524321
    [No Abstract]   [Full Text] [Related]  

  • 10. [Vaccines against HIV].
    Holm-Hansen C
    Tidsskr Nor Laegeforen; 2006 Nov; 126(23):3117-20. PubMed ID: 17160118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic vaccination against HIV: current progress and future possibilities.
    Puls RL; Emery S
    Clin Sci (Lond); 2006 Jan; 110(1):59-71. PubMed ID: 16336205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic vaccines against HIV need international partnerships.
    Autran B; Debré P; Walker B; Katlama C
    Nat Rev Immunol; 2003 Jun; 3(6):503-8. PubMed ID: 12776210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential role of the HIV-1 immunogen (Remune) as a therapeutic vaccine in the treatment of HIV infection.
    Fernández-Cruz E; Navarro J; Rodríguez-Sainz C; Gil J; Moreno S; González-Lahoz J; Carbone J
    Expert Rev Vaccines; 2003 Dec; 2(6):739-52. PubMed ID: 14711358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HIV vaccination].
    Jablonowski H
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():68-9. PubMed ID: 19031568
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunotherapy of HIV infection].
    Harrer T
    Wien Med Wochenschr; 1998; 148(23-24):560-6. PubMed ID: 10189687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A primer on HIV type 1-specific immune function and REMUNE.
    Moss RB; Giermakowska WK; Savary JR; Theofan G; Daigle AE; Richieri SP; Jensen FC; Carlo DJ
    AIDS Res Hum Retroviruses; 1998 Jun; 14 Suppl 2():S167-75. PubMed ID: 9672235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term HIV-specific responses and delayed resumption of antiretroviral therapy after peptide immunization targeting dendritic cells.
    Kran AM; Sørensen B; Sommerfelt MA; Nyhus J; Baksaas I; Kvale D
    AIDS; 2006 Feb; 20(4):627-30. PubMed ID: 16470131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with therapeutic AIDS vaccines.
    Bourinbaiar AS; Abulafia-Lapid R
    Expert Rev Vaccines; 2005 Jun; 4(3):289-304. PubMed ID: 16026245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HIV/AIDS vaccines: heading for new vaccine approaches?].
    Girard MP
    Bull Soc Pathol Exot; 2008 Jun; 101(3):220-6. PubMed ID: 18681215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination against drug resistance in HIV infection.
    Boberg A; Isaguliants M
    Expert Rev Vaccines; 2008 Feb; 7(1):131-45. PubMed ID: 18251699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.